BACKGROUND: A proposed revision of sepsis definitions has abandoned the systemic inflammatory response syndrome (SIRS), defined organ dysfunction as an increase in total Sequential Organ Function Assessment (SOFA) score of $ 2, and conceived "qSOFA" (quick SOFA) as a bedside indicator of organ dysfunction. We aimed to (1) determine the prognostic impact of SIRS, (2) compare the diagnostic accuracy of SIRS and qSOFA for organ dysfunction, and (3) compare standard (Sepsis-2) and revised (Sepsis-3) definitions for organ dysfunction in ED patients with infection.
Infectious diseases have plagued mankind for millennia 1 and remain a major cause of morbidity and mortality. 2 Despite this, the complex pathophysiological response to infection remains to be fully elucidated, and a gold standard test for serious infection (or colloquially, "sepsis") does not currently exist. In the absence of a gold standard test, several groups have attempted to provide clinical criteria for the identification of infected patients at risk of significant mortality.
Consensus conferences in 1991 3 and 2001 4 proposed that sepsis be defined as infection with systemic inflammatory response syndrome (SIRS), and severe sepsis as sepsis with consequent organ dysfunction. The Sequential Organ Function Assessment (SOFA) 5 score was a suggested means to quantify dysfunction in each of six organ systems. Within this framework, sepsis research has advanced with promulgation of evidencebased guidelines for sepsis management, 6 and global sepsis mortality has been reduced. 7 A recently proposed revision of sepsis definitions (Sepsis-3) 8 has discarded SIRS, with concerns that most patients with SIRS do not have infection 9 and that SIRS is absent in some patients with infection in a critical care setting. 10 Sepsis-3 has also redefined organ dysfunction as an increase in the total SOFA score of $ 2 rather than the previous convention of using specified criteria to determine dysfunction in each of several organ systems. A new construct, quick (q)SOFA, has also been introduced in Sepsis-3 as a means to screen for organ dysfunction at the bedside using respiratory rate, blood pressure, and conscious state.
However, the original definitions intended SIRS be regarded as a potential severity indicator in patients with suspected infection rather than a screening test for infection. In the ICU, SIRS is common 11 and contributes minimally to mortality risk. 12 As noted in a recent editorial critical of the revised definitions, 13 SIRS is more likely to be useful in the ED, where patients with infection are common and a parsimonious means to screen for those at higher risk of mortality is required.
There are few studies specifically examining the prognostic utility of SIRS in ED patients with infection, and the SOFA and qSOFA scores remain to be evaluated in those patients. The purpose of this study was to determine the following in ED patients with suspected infection: (1) the prevalence and prognostic impact of SIRS, (2) the diagnostic accuracy of SIRS and qSOFA for organ dysfunction, and (3) the characteristics and utility of the current (Sepsis-2) and proposed (Sepsis-3) SOFAbased organ dysfunction criteria.
Methods

Study Design and Setting
The prospective observational database used for this study was designed to examine the performance of SIRS and SOFA-based organ dysfunction as originally described for Sepsis-2. Following the recent publication of the proposed Sepsis-3 definitions, the study scope was expanded retrospectively to include analysis of the new definitions. The study was undertaken in the ED of a tertiary university-affiliated Australian hospital with an annual census of > 72,000 adult presentations. 
Participants, Methods, and Measurements
Methods have been described in detail 14 but are briefly summarized here. On a daily basis, patients seen in the ED and subsequently admitted with a diagnosis indicating presumed or potential infection were identified. The charts of those patients were examined by trained data collectors. Patients were enrolled if the ED and admitting medical staff both indicated that infection was the most likely reason for admission. Patients transferred from other hospitals or aged < 17 years were not enrolled.
Data were abstracted from the paper chart at the time of each patient's enrollment and included physiological measurements and treatment in the ED, presumed source of infection, and comorbidities. At a later time, results of hematologic and biochemical tests were obtained from computerized hospital databases. Data were entered into a Microsoft Access database and stored on a password-protected secure hospital drive. Regular automated checks for out-of-range entries were conducted, and the principal investigator reviewed accuracy of the data for all patients. The database was designed to comply with the components of the Strengthening the Reporting of Observational studies in Epidemiology statement.
For each physiological parameter, the most abnormal measurement in the ED was recorded. SIRS was defined as two or more of the following: heart rate > 90 beats/min, respiratory rate > 20 breaths/ min or arterial carbon dioxide pressure < 32 mm Hg, leukocyte count > 12,000/mL or < 4,000/mL, and temperature < 36 C or $ 38 C. The recorded components of qSOFA were respiratory rate $ 22/min, systolic blood pressure # 100 mm Hg, and Glasgow Coma Score (GCS) # 13. Organ function was assessed using a modified SOFA score (e- Table 1 ). Hospital records relating to previous admissions and outpatient and ED encounters were used to assess and record baseline organ function, which was assumed to be normal in the absence of such data. Consistent with definitions in place during data collection (Sepsis-2), acute organ dysfunction was defined for primary analyses as an increase in SOFA score of $ 2 in any discrete organ system. For comparison, the proposed new definition of acute organ dysfunction (Sepsis-3) was an increase in total SOFA score of two or more. Shock was defined as hypotension (systolic blood pressure < 90 mm Hg) persisting despite at least a 1,000-mL fluid bolus or vasopressor infusion in the ED (corresponding to a cardiovascular SOFA score of $ 2). The Charlson score 15 was calculated to quantify comorbidity. The journal.publications.chestnet.org primary outcome measure was 30-day mortality, and the secondary outcome was 1-year mortality. Both were obtained from a national death registry.
Analysis
Analyses were performed using Stata, version 14 (StataCorp LC). In cases of readmission within 90 days, a single representative admission was selected at random from within that period for inclusion in the study data set. Baseline characteristics of the study sample were reported by vital status at 30 days. Risk ratios and risk differences (with 95% CIs) were calculated to identify the prognostic utility of SIRS for mortality in patients with and those without organ dysfunction. ORs adjusted for age and comorbidity were also reported. Because of the nonlinear relationship between age and mortality, age was stratified into 10-year categories for computation of adjusted ORs. The Charlson comorbidity index was stratified into 0, 1 to 2, 3 to 4, and $ 5 as originally described. 15 Discrimination of SIRS and qSOFA scores for organ dysfunction and mortality was quantified using receiver operating curves. Sensitivity and specificity corresponding to SIRS $ 2 and qSOFA $ 2 were reported. Adjusted ORs for mortality were calculated for each of the SIRS and qSOFA criteria, each individual (Sepsis-2) organ system dysfunction, Sepsis-2 and Sepsis-3 organ dysfunction, and cumulative (Sepis-2) organ dysfunction.
A number of sensitivity analyses were conducted. First, analyses were repeated using multiple imputation of missing data to identify whether the assumption of normality in the primary analysis resulted in biased estimates. This resulted in imputation for 21 patients (0.2%) with missing white cell count data and 242 patients (2.7%) with any missing SOFA score components. Analyses conducted using multiple imputation yielded similar estimates so were not reported. Second, to inform discussion regarding definitions of acute organ dysfunction, mortality was computed for different SOFA score thresholds.
Results
Patient recruitment and classification into groups according to SIRS and organ dysfunction is outlined in Figure 1 . The study cohort comprised 8,871 admissions of patients with presumed infection over the total study duration of 160 weeks, after exclusion of 846 readmissions within 90 days. Numbers and characteristics of included and excluded representations are detailed in e- Table 2 . Table 2 compares the prevalence and prognostic implications of SIRS in subgroups with and without organ dysfunction and with shock. In the overall cohort, SIRS was associated with increased risk of (Sepsis-2) organ dysfunction (relative risk [RR], 3.5; 95% CI, 3.1-3.8) and increased odds of mortality in patients without (Sepsis-2) organ dysfunction (OR, 3.2; 95% CI, 2.2-4.7). SIRS had similar implications when Sepsis-3 was used to determine organ dysfunction. SIRS was present in 1,157 patients (75.4%) with (Sepsis-2) organ dysfunction and was associated with increased odds of mortality compared with the 377 patients (24.6%) without SIRS (OR, 1.8; 95% CI, 1.2-2.7). Similarly, in those with Sepsis-3 organ dysfunction (n ¼ 1,561 with SIRS and 605 without SIRS), SIRS was associated with increased odds of 30-day mortality (OR, 2.2; 95% CI, 1.5-3.1). However, at 1 year, there was no association between SIRS and prognosis in patients with organ dysfunction according to either definition. In patients with shock, SIRS was present in 89% and was not associated with increased mortality at either end point. As defined in this study, patients with Sepsis-2 organ dysfunction composed a subgroup of those with Sepsis-3 organ dysfunction. The 632 patients that met Sepsis-3 but not Sepsis-2 criteria for organ dysfunction presented with an acute increase in total SOFA score of $ 2, but that increase occurred in different organ systems. Mortality for those patients was significantly less than for those with Sepsis-2 organ dysfunction at 30 days (difference, 3.6%; 95% CI, 0.8%-6.4%) but not at 1 year (difference -2.6%; 95% CI, -6.8 to 1.5%). The relationships between study groups according to Sepsis-2 and Sepsis-3 definitions are illustrated graphically in Figure 2 . The last four rows of Table 2 and Figure 2D represent a potential compromise structure that recognizes that SIRS is associated with increased mortality in patients without organ dysfunction but is prognostically less important when organ dysfunction or shock is present.
SIRS and qSOFA scores showed similar discrimination for Sepsis-3 organ dysfunction (area under the receiver operating curve, 0.72 vs 0.73; difference, 0.01; 95% CI, 0.0-0.03) (Fig 3) . A qSOFA score $ 2 had high specificity for Sepsis-3 organ dysfunction but poor sensitivity (96.1%; 95% CI, 95.7%-96.6% and 29.9%; 95% CI, 27.9%-31.8%, respectively). Specificity and sensitivity for SIRS $ 2 were 61.1% (95% CI, 60.0%-62.3%) and 72.3% (95% CI, 70.3%-74.1%). e- Figure 1 shows results using the end point of 30-day mortality.
Using Sepsis-2, the odds of mortality increased with a greater number of organ system dysfunctions (Fig 4) . Substantial variation was seen in the odds of mortality associated with dysfunction in individual organ systems (Table 3) . CNS dysfunction was associated with the greatest mortality risk (OR, 11.2; 95% CI, 7.1-17.7), with hematologic dysfunction lowest and failing to achieve statistical significance (OR, 1.6; 95% CI, 0.9-2.9). e- Table 3 examines the implications of defining Sepsis-2 organ dysfunction at varying SOFA scores in each organ system. Mortality odds for each of the SIRS and qSOFA components are also presented in Table 3 . Among these, altered conscious state was again the most powerful predictor.
Discussion
In this large prospective study of ED patients with suspected infection of all severities, SIRS was found to be a useful marker of organ dysfunction and mortality, whereas qSOFA had high specificity for organ dysfunction but poor sensitivity. Organ dysfunction was associated with 30-day mortality slightly > 10%, without a significant difference between values obtained with Sepsis-2 and those obtained with Sepsis-3. Using Sepsis-2, an increasing number of discrete organ system dysfunctions increased mortality, but dysfunction in individual organ systems was associated with a wide variation in mortality risk.
SIRS in the ED
Previous investigators have found that SIRS is not useful for predicting which patients in hospital wards 9 or the ED 16,17 have infection. While some components of SIRS may contribute to a clinician's judgment regarding the presence of infection, that assessment is ultimately based on a range of physiological, investigational, and heuristic criteria because a gold standard does not yet exist. This paper examines the role of SIRS as a prognostic marker in ED patients with suspected infection. There are few previous studies with this aim. Shapiro et al 18 found no relationship between SIRS and mortality in ED patients with suspected infection and no organ dysfunction (OR, 0.8; 95% CI, 0.4-1.6). The 3,102 patients in that study were identified on the basis of blood culture requests and included Combination refers to a potential framework that recognizes that SIRS is associated with substantially increased mortality only in the absence of organ dysfunction. See Table 1 legend for expansion of abbreviations.
journal.publications.chestnet.org patients discharged home from the ED. More recently, a larger Danish study 19 also used blood culture requests to identify 5,499 ED patients admitted with infection and found that SIRS was associated with increased mortality (HR, 1.5; 95% CI, 1.2-1.7). Marchick and Jones 20 also found SIRS to be associated with significantly greater mortality in a cohort of 1,031 ED patients with suspected infection (6.5% vs 1.4%; P ¼ .02), but those investigators expanded SIRS criteria to include hyperglycemia and altered mental state. Our study examined the largest prospective cohort of ED patients with suspected infection to date and found SIRS to be associated with increased risk of organ dysfunction and mortality at 30 days and 1 year. The proposed Sepsis-3 definitions discarded SIRS and nominated organ dysfunction as an indicator of deleterious and dysregulated response to infection. Our results establish that SIRS is also associated with increased risk of deleterious response to infection and mortality.
SIRS in Patients With Organ Dysfunction
Depending on the method used, we found that 24.6% (Sepsis-2) to 27.9% (Sepsis-3) of patients with organ dysfunction did not have SIRS. Other investigators have reported similar figures. 18, 21, 22 In our study, SIRS was associated with a modest increase in 30-day mortality risk in patients with infection and organ dysfunction, but this effect was not evident at 1 year. We could identify only one previous study designed to examine the prognostic effect of SIRS in patients with infection and organ dysfunction seen in the ED. In that study, Henriksen et al 22 found that SIRS was present in 75.8% of 1,169 patients seen in the ED and admitted with infection and organ dysfunction, and did not confer increased mortality risk (adjusted HR, 1.17; 95% CI, 0.84-1.64). Studies in patients with infection in the ICU have concluded that SIRS adds little to the prognosis in the context of organ dysfunction and shock. 12 Kaukonen et al 10 finding SIRS to be present in 87.9% and not associated with mortality in an adjusted analysis. In our study, patients with shock (mortality, 23.8%) had SIRS in 89% of cases, with SIRS also not associated with mortality.
Organ Dysfunction
Overall organ dysfunction according to both Sepsis-2 and Sepsis-3 provided similar estimates of mortality risk. The capacity to denote dysfunction in each of the six SOFA organ systems (Sepsis-2) allowed the identification of patients with dysfunction in multiple organ systems. This classification was important prognostically, with mortality increasing according to the number of organs affected; it could also provide relevant clinical information that may indicate the requirement for particular interventions and organ support. Increasing mortality with cumulative organ dysfunction was also observed in the study from Shapiro et al, 18 although the criteria used to determine organ dysfunction were not SOFA based. Our analyses found that mortality associated with each individual organ dysfunction varied widely (Table 3 ) despite the same SOFA threshold (increase of 2 or more) applying to each. e- Table 2 enables comparison of mortality in each organ system as the threshold is increased from one to four. A CNS SOFA cutoff of 1 (any reduction in consciousness) is associated with outcomes similar to dysfunction in the other major organ systems. Furthermore, even at SOFA cutoffs of 3 or more, gastrointestinal and hematologic organ system dysfunction remains less important prognostically than dysfunction in other systems. The poor calibration of the SOFA score between organ systems seen in our study may be related to its use in the ED setting and the fact that the SOFA score dates from 1996. Limitations in the SOFA score will also affect Sepsis-3 organ dysfunction criteria and might be reduced by recalibrating the score with contemporary patient data. The 29% of patients with Sepsis-3 but not Sepsis-2 organ dysfunction presented with an increase in SOFA score by 1 in two or more different organ systems. Mortality in this group was less than with Sepsis-2 organ dysfunction at 30 days (but similar at 1 year), creating some uncertainty about whether these patients should be regarded to have organ dysfunction.
SIRS and qSOFA
The qSOFA score has been proposed as a parsimonious bedside tool to screen patients with infection for those at journal.publications.chestnet.org risk of organ dysfunction and death. 8 Overall discrimination for organ dysfunction was similar for SIRS and qSOFA, but specificity and sensitivity differed at operating cutoffs of SIRS $ 2 and qSOFA $ 2. Despite qSOFA $ 2 being highly specific for Sepsis-3 organ dysfunction and mortality (96.1% and 91.3%, respectively), sensitivity was poor (29.7% and 49.1%) compared with sensitivity for SIRS $ 2 (72.1% and 76.7%, respectively). Given the relative insensitivity of a qSOFA score $ 2, it appears inferior to a SIRS score $ 2 as a screening test in the ED, where the timely identification of high-risk infected patients is paramount.
Study Limitations and Strengths
The methods used to identify patients may not have identified all ED patients admitted with infection, and not all included patients may have ultimately been shown to have infection. However, it is likely that any method chosen to identify patients with infection of all severities in large enough numbers for meaningful analyses would have similar limitations. We aimed to minimize these issues by using a broad list of ED admission diagnoses indicating possible infection to screen for enrollment candidates and including only those in whom both ED and admitting teams concurred that infection was the most likely cause of admission. Our methods were entirely observational, and therefore data collected were limited to those generated in the course of standard investigation and treatment for each patient. Despite this, missing data were minimal as reported. Our study was undertaken at a single center, which may limit generalizability. We used a modified SOFA score for ED patients, and this may influence the number of patients categorized as having organ dysfunction. Derivation of the Sepsis-3 criteria incorporated a secondary end point of mortality or ICU admission of $ 3 days, or both. Consistent with the primary end point of mortality, our analyses have assessed the performance of Sepsis-3 criteria against mortality at 30 days and 1 year but have not assessed this secondary end point.
Strengths of our study include the prospective enrollment of a large cohort of ED patients admitted with suspected infection and reliable short-term and long-term mortality end points sourced from a national database. Use of the SOFA score has enabled a comparison between alternative definitions of organ dysfunction in the context of infection, and ours is the first assessment of the proposed Sepsis-3 criteria in the ED.
Conclusions
Our results indicate that SIRS is a useful screening tool for organ dysfunction and death in ED patients with suspected infection. SIRS contributed less to prognosis in the context of organ dysfunction or shock, arguing against including SIRS as a requirement for entry into trials enrolling patients with severe sepsis and septic shock. Patients with organ dysfunction according to either Sepsis-2 or Sepsis-3 criteria had similar mortality. Reporting multiple organ dysfunctions (Sepsis-2) allows a description containing more prognostic and clinically relevant information. The wide variation in mortality risk associated with a SOFA score of 2 in each organ system indicates that the SOFA score may require calibration for use in the ED.
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